Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 31, 2009

Premium

Rosetta Genomics has added two new directors to its board.

The first, David Sidransky, is a professor and director of the head and neck cancer research division at Johns Hopkins University School of Medicine. He previously served as vice chairman of the board of biotech shop ImClone and is currently chairman of the board of Alfacell and Champions Biotechnology.

The second, Kenneth Berlin, was recently named Rosetta's president and CEO.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.